Certolizumab Subcutaneous and Dexrazoxane Intravenous
Determining the interaction of Certolizumab Subcutaneous and Dexrazoxane Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: certolizumab
Brand name: Cimzia, Cimzia Starter
Synonyms: Certolizumab, Certolizumab Pegol
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Certolizumab Subcutaneous-Dextenza Insert
- Certolizumab Subcutaneous-Dextenza intraocular
- Certolizumab Subcutaneous-Dextran 40
- Certolizumab Subcutaneous-Dextran 70 6% in 5% Dextrose high molecular weight
- Certolizumab Subcutaneous-Dextran 75
- Certolizumab Subcutaneous-Dextran high molecular weight
- Dexrazoxane Intravenous-Certolizumab Vials
- Dexrazoxane Intravenous-Cerubidine
- Dexrazoxane Intravenous-Cervarix
- Dexrazoxane Intravenous-Cervarix Intramuscular
- Dexrazoxane Intravenous-Cervidil
- Dexrazoxane Intravenous-Cesamet